153 related articles for article (PubMed ID: 38057344)
1. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer.
Zu L; He J; Zhou N; Tang Q; Liang M; Xu S
Cell Death Dis; 2023 Dec; 14(12):798. PubMed ID: 38057344
[TBL] [Abstract][Full Text] [Related]
2. [Screening and establishment of human lung cancer cell lines with organ-specific metastasis potential].
Zhou Q; Zu L; Li L; Chen X; Chen X; Li Y; Liu H; Sun Z
Zhongguo Fei Ai Za Zhi; 2014 Mar; 17(3):175-82. PubMed ID: 24667252
[TBL] [Abstract][Full Text] [Related]
3. MiR-7-5p suppresses tumor metastasis of non-small cell lung cancer by targeting NOVA2.
Xiao H
Cell Mol Biol Lett; 2019; 24():60. PubMed ID: 31832068
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
5. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
Liu MX; Zhou KC; Cao Y
Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
[TBL] [Abstract][Full Text] [Related]
6. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
[TBL] [Abstract][Full Text] [Related]
7. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells.
Iacona JR; Monteleone NJ; Lemenze AD; Cornett AL; Lutz CS
RNA Biol; 2019 Dec; 16(12):1721-1732. PubMed ID: 31425002
[TBL] [Abstract][Full Text] [Related]
9. Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature.
Tsakonas G; Koulouris A; Kazmierczak D; Botling J; Ortiz-Villalon C; Nord H; Lindskog M; Sandelin M; Micke P; Hydbring P; Ekman S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613642
[TBL] [Abstract][Full Text] [Related]
10. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
11. Two microRNAs of plasma-derived small extracellular vesicles as biomarkers for metastatic non-small cell lung cancer.
Geng N; Qi Y; Qin W; Li S; Jin H; Jiang Y; Wang X; Wei S; Wang P
BMC Pulm Med; 2023 Jul; 23(1):259. PubMed ID: 37452310
[TBL] [Abstract][Full Text] [Related]
12. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M; Zhou K; Huang Y; Cao Y
J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
[TBL] [Abstract][Full Text] [Related]
13. miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25.
Li J; Tan Q; Yan M; Liu L; Lin H; Zhao F; Bao G; Kong H; Ge C; Zhang F; Yu T; Li J; He X; Yao M
Mol Cancer; 2014 Jul; 13():166. PubMed ID: 24997798
[TBL] [Abstract][Full Text] [Related]
14. MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.
Liu F; Cai Y; Rong X; Chen J; Zheng D; Chen L; Zhang J; Luo R; Zhao P; Ruan J
Mol Cancer; 2017 Jul; 16(1):122. PubMed ID: 28716024
[TBL] [Abstract][Full Text] [Related]
15. Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts.
Ni J; Zhang X; Li J; Zheng Z; Zhang J; Zhao W; Liu L
Cell Death Dis; 2021 Jul; 12(7):662. PubMed ID: 34215717
[TBL] [Abstract][Full Text] [Related]
16. CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p.
Li J; Tang Z; Wang H; Wu W; Zhou F; Ke H; Lu W; Zhang S; Zhang Y; Yang S; Ni S; Huang J
Biomed Pharmacother; 2018 Jan; 97():1182-1188. PubMed ID: 29136957
[TBL] [Abstract][Full Text] [Related]
17. Study on the Potential Mechanism of miR-22-5p in Non-Small-Cell Lung Cancer.
Han X; Li H; Liu S; Zhao Z
Dis Markers; 2022; 2022():3750734. PubMed ID: 36111260
[TBL] [Abstract][Full Text] [Related]
18. Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5.
Ai C; Ma G; Deng Y; Zheng Q; Gen Y; Li W; Li Y; Zu L; Zhou Q
Thorac Cancer; 2020 Mar; 11(3):640-650. PubMed ID: 32022430
[TBL] [Abstract][Full Text] [Related]
19. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.
Liang G; Meng W; Huang X; Zhu W; Yin C; Wang C; Fassan M; Yu Y; Kudo M; Xiao S; Zhao C; Zou P; Wang Y; Li X; Croce CM; Cui R
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4347-4357. PubMed ID: 32041891
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
